Agios Pharmaceuticals
AGIO
$34.34
Share price
-1.89%
Change (1 day)
32.18%
Change (1 year)
Categories
Earnings for Agios Pharmaceuticals (AGIO)
Earnings in 2023 (TTM): -$0.4 B
According to Agios Pharmaceuticals 's latest financial reports the company's current earnings (TTM) are -$0.4 B. In 2022 the company made an earning of -$0.39 B a decrease over its 2021 earnings that were of -$0.38 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Agios Pharmaceuticals from 2012 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$0.4 B | 0.63% |
| 2022 | -$0.39 B | 2.81% |
| 2021 | -$0.38 B | 10.58% |
| 2020 | -$0.35 B | -18.41% |
| 2019 | -$0.42 B | 15.72% |
| 2018 | -$0.37 B | 12.99% |
| 2017 | -$0.33 B | 59.61% |
| 2016 | -$0.21 B | 69.32% |
| 2015 | -$0.12 B | 119.28% |
| 2014 | -$54.14 M | 39.22% |
| 2013 | -$38.89 M | 69.1% |
| 2012 | -$23 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $3.26 B | -934.51% | 🇺🇸 USA |
 Eli Lilly LLY | $7.56 B | -2,031.35% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $6.88 B | -1,858.71% | 🇬🇧 UK |
 Xencor XNCR | -$0.13 B | -69.24% | 🇺🇸 USA |
 Exelixis EXEL | $0.25 B | -166.03% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $0.23 B | -160.63% | 🇺🇸 USA |